However, multiple reports indicate that, in addition to increased LAP, factors outside the heart, including arterial and skeletal muscle dysfunction, can account for up to 50% or more of the reduction in exercise capacity in chronic HFpEF, and account for most of the improvement after exercise training and caloric restriction, the only interventions currently known to improve exercise intolerance in chronic HFpEF (2) . Furthermore, approximately 50% of clinical outcomes in patients with acute HFpEF are related to extracardiac factors, including multiple comorbitdities (3). This has led to a broader view of HFpEF as a systemic syndrome that involves multiple organs and has multifactorial causality and a heterogenous population (4). Systemic inflammation seems to be involved in initiating and/or promoting this systemic process, but the exact mediators have yet to be identified.
In a systemic, multiorgan paradigm of HFpEF, the pulmonary system is the most obvious extracardiac contributor to the pivotal symptom of dyspnea.
Nearly two-thirds of HFpEF patients have chronic obstructive pulmonary disease (1) . Patients with HF with reduced ejection fraction (HFrEF) have several specific pulmonary abnormalities that contribute to their symptoms, exercise intolerance, and poor outcomes. Recently, Andrea et al. (5) showed that 94% of newly diagnosed HFpEF patients have abnormal lung function, including ventilation (59%), diffusion capacity (83%), and arterial hypoxemia (63%). These significant abnormalities were usually unrecognized clinically.
In this issue of JACC: Heart Failure, Olson et al. (6) report results of an elegant study that significantly extends our understanding of pulmonary abnormalities in HFpEF, identifies the mechanisms for the abnormal diffusion capacity, and documents their relation to exercise intolerance in HFpEF.
As background, animal studies have shown previously that an alveolar-capillary membrane stress failure phenomenon can occur when lung capillaries are exposed to acute excessive increases in hydrostatic pressure (7) . This is related to endothelial and no relationships relevant to the contents of this paper to disclose. Lung microvascular injury and capillary remodeling are also present (9).
Although remodeling may allow patients to chronically tolerate higher pulmonary venous pressures without developing overt pulmonary edema, it also challenges fundamental gas exchange physiology Because LAP and pulmonary vascular resistance were not measured, the present study was not able to examine potential hemodynamic determinants of these vascular and gas exchange abnormalities (6). 
